In renal cell carcinoma and pulmonary interstitial fibrosis, TRB3 enhances cell viability and invasiveness by targeting the ERK, JNK, and p38 MAPK signaling pathways [21, 29]. Here, TRIB3 is linked to pulmonary fibrosis.